Interim report of research collaboration with Seoul National University College of Medicine testing antiviral efficacy of NOVO-NK on COVID-19.
최고관리자
0
519
07-06
The following is the interim report of the antiviral effect of NOVO-NK on COVID-19.
Please understand that sensitive technical information of the research is purposely omitted to prevent technology leaks.
[Results]
The official research standards Ministry of Food and Drug Safety were used to conduct the experiment.
The results were analyzed by dyeing nuclear protein of COVID-19
When infected VeroE6 cells were treated by NOVO-NK, the majority of COVID-19 virus were eliminated in a 6-hour period.
The experiment proved a promising antiviral effect of NOVO-NK treatment on COVID-19.
The company will proceed to develop treatments for both COVID-19 and mutated viruses.
Please understand that sensitive technical information of the research is purposely omitted to prevent technology leaks.
[Results]
The official research standards Ministry of Food and Drug Safety were used to conduct the experiment.
The results were analyzed by dyeing nuclear protein of COVID-19
When infected VeroE6 cells were treated by NOVO-NK, the majority of COVID-19 virus were eliminated in a 6-hour period.
The experiment proved a promising antiviral effect of NOVO-NK treatment on COVID-19.
The company will proceed to develop treatments for both COVID-19 and mutated viruses.